Back to today’s briefing

Story perspectives

U.S. Invests $590M in Moderna for Avian Flu Vaccines

1/24/2025

50 9

Summary

Story summary

The U.S. Department of Health and Human Services is investing $590 million in Moderna to develop mRNA vaccines against the avian influenza strains H5N1 and H7N9. This crucial funding seeks to bolster pandemic preparedness amid rising infectious diseases, even as the CDC reassures the public of a low health risk despite 67 reported human cases and one death.

1 of 1

Story summary

The U.S. Department of Health and Human Services is investing $590 million in Moderna to develop mRNA vaccines against the avian influenza strains H5N1 and H7N9. This crucial funding seeks to bolster pandemic preparedness amid rising infectious diseases, even as the CDC reassures the public of a low health risk despite 67 reported human cases and one death.